Tizanidine
- Product NDC
- 45865-386
- 11-digit product format
- 458650386
- Labeler code
- 45865
- Product ID
- 45865-386_d78e34e6-d2eb-4bfa-8a9f-5f5768345599
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Medsource Pharmaceuticals
- Application
- ANDA076286
- Marketing category
- ANDA
- Marketing start
- 2009-01-05
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45865-386-30 | Tizanidine | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 45865-386-49 | Tizanidine | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 45865-386-51 | Tizanidine | 120 in 1 BOTTLE | TABLET | 120 | | 2 |
| 45865-386-60 | Tizanidine | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
| 45865-386-90 | Tizanidine | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45865-386 | TIZANIDINE TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | Legacy NDC, 5 package rows | 20120818_5a42267f-a400-4bfd-ad7c-fad335884ba8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 45865-386-30 | 45865038630 | 30 in 1 BOTTLE | Historical |
| 45865-386-49 | 45865038649 | 100 in 1 BOTTLE | Historical |
| 45865-386-51 | 45865038651 | 120 in 1 BOTTLE | Historical |
| 45865-386-60 | 45865038660 | 60 in 1 BOTTLE | Historical |
| 45865-386-90 | 45865038690 | 90 in 1 BOTTLE | Historical |